By Karunjit Singh (December 22, 2023, 3:43 PM EST) -- The Federal Court has denied approval for a generic equivalent of a patented glaucoma medication, rejecting arguments that the patent on the medication, which was an improvement over a previous formulation, was invalid because the invention was obvious....